DEUS pilot trial baseline participant characteristics
| Characteristic | Shape-Up (n=25) | Care as usual (n=24) | Total |
| Age, mean (SD) | 62.6 (9.0) | 61.5 (7.7) | 62.1 (8.3) |
| Race | |||
| White | 17 (68) | 16 (67) | 33 (67) |
| Asian | 4 (16) | 5 (21) | 9 (18) |
| Other | 4 (16) | 3 (12) | 7 (14) |
| Living arrangement | |||
| Own outright/mortgage | 17 (68) | 15 (63) | 32 (65) |
| Rent | 8 (30) | 9 (38) | 17 (35) |
| Marital status | |||
| Married/living with partner/civil partnership | 12 (48) | 15 (63) | 27 (55) |
| Separated/divorced | 7 (28) | 3 (12) | 10 (20) |
| Widowed/single | 6 (24) | 6 (25) | 12 (24) |
| Education | |||
| Degree/higher degree/higher education below degree level | 11 (44) | 12 (50) | 23 (47) |
| Secondary education | 11 (44) | 10 (42) | 21 (42) |
| No formal qualifications | 3 (12) | 2 (8) | 5 (10) |
| Employment | |||
| Full time/self-employed | 9 (36) | 11 (46) | 20 (41) |
| Part time/other | 6 (24) | 2 (8) | 8 (16) |
| Retired | 10 (40) | 11 (46) | 21 (43) |
| Smoking | |||
| Current | 2 (8) | 2 (8) | 4 (8) |
| Former | 4 (16) | 5 (21) | 9 (18) |
| IMD (quintile) | |||
| 1 (most deprived) | 5 (20) | 4 (17) | 9 (18) |
| 2 | 9 (36) | 6 (25) | 15 (31) |
| 3 | 4 (16) | 7 (29) | 11 (22) |
| 4 | 3 (12) | 3 (13) | 6 (12) |
| 5 (least deprived) | 4 (16) | 4 (17) | 8 (16) |
| Time since diagnosis in months, mean (SD) | 19.2 (11.2) | 21.4 (11.3) | 20.3 (11.2) |
| Time since completion of primary treatment in months, mean (SD) | 17.1 (11.2) | 18.5 (11.7) | 17.8 (11.3) |
| Surgery | 25 (100) | 24 (100) | 49 (100) |
| Chemotherapy treatment | 3 (12) | 5 (21) | 8 (16) |
| External beam radiotherapy | 6 (24) | 12 (50) | 18 (37) |
| Brachytherapy | 11 (44) | 13 (54) | 24 (49) |
| Cancer stage | |||
| IA | 11 (44) | 13 (54) | 24 (49) |
| IB | 11 (44) | 6 (25) | 17 (35) |
| II | 2 (8) | 3 (13) | 5 (10) |
| IIIA | 1 (4) | 2 (8) | 3 (6) |
| Cancer grade | |||
| 1 | 6 (24) | 7 (29) | 13 (27) |
| 2 | 13 (52) | 9 (38) | 22 (45) |
| 3 | 6 (24) | 8 (33) | 14 (29) |
| Histology | |||
| Endometrioid adenocarcinoma | 21 (84) | 19 (79) | 40 (82) |
| Serous carcinoma | 1 (4) | 3 (13) | 4 (8) |
| Mixed carcinoma | 1 (4) | 0 (0) | 1 (2) |
| Serous surface papillary carcinoma | 0 (0) | 1 (4) | 1 (2) |
| Carcinosarcoma | 2 (8) | 0 (0) | 2 (4) |
| Adenosquamous carcinoma | 0 (0) | 1 (4) | 1 (2) |
| Histological type | |||
| Type I | 21 (84) | 19 (79) | 40 (82) |
| Type II | 4 (16) | 5 (21) | 9 (18) |
| Charlson Comorbidity Index | |||
| 2 | 18 (75) | 21 (84) | 39 (80) |
| 3 | 6 (25) | 4 (16) | 10 (20) |
| WHO performance status | |||
| 0 | 20 (83) | 20 (80) | 40 (82) |
| 1 | 3 (13) | 5 (20) | 8 (16) |
| 2 | 1 (4) | 0 (0) | 1 (2) |
| Selected comorbidities | |||
| Diabetes | 3 (12) | 4 (17) | 7 (14) |
| Hypertension | 6 (24) | 7 (29) | 13 (27) |
| Dyslipidaemia | 3 (12) | 3 (13) | 6 (12) |
| Asthma | 1 (4) | 2 (8) | 3 (6) |
| Osteoporosis | 2 (8) | 4 (17) | 6 (12) |
| Weight, mean kg (SD) | 69.8 (14.8) | 71.9 (15.2) | 70.9 (14.9) |
| BMI, mean kg/m2 (SD) | 27.3 (6.5) | 28.8 (6.1) | 28.0 (6.3) |
| BMI, median kg/m2 (IQR) | 26.2 (24.3) | 26.9 (8.6) | 26.8 (6l.4) |
| % Fat, mean (SD) | 35.3 (7.7) | 36.9 (6.3) | 36.1 (7.0) |
Percentages might not add to 100 due to rounding.
Data are presented as n (%) unless otherwise specified.
Body composition data for usual care n=23.
BMI, body mass index; DEUS, Diet and Exercise in Uterine Cancer Survivors; IMD, index of multiple deprivation.